Estrogen Receptor-Positive and Estrogen Receptor-Negative Human Breast Cancer Cells: Regulation of Expression of Cancer-Related Genes by Estradiol and Tamoxifen

Publisher： Bentham Science Publishers

E-ISSN： 2212-389x|3|1|7-21

ISSN： 1574-3624

Source： Current Signal Transduction Therapy, Vol.3, Iss.1, 2008-01, pp. : 7-21

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Role of AIB1 for Tamoxifen Resistance in Estrogen Receptor-Positive Breast Cancer Cells

By  

Oncology, Vol. 75, Iss. 3-4, 2008-10 ,pp. : 159-168

Karger

Access to resources Recommend Favorite

Active smoking and the risk of estrogen receptor‐positive and triple‐negative breast cancer among women ages 20 to 44 years

By  

CANCER, Vol. 120, Iss. 7, 2014-04 ,pp. : 1026-1034

John Wiley & Sons Inc

Access to resources Recommend Favorite

Treatment with bisphenol A and methoxychlor results in the growth of human breast cancer cells and alteration of the expression of cell cycle-related genes, cyclin D1 and p21, via an estrogen receptor-dependent signaling pathway

By            

International Journal of Molecular Medicine, Vol. 29, Iss. 5, 2012-01 ,pp. : 883-890

Spandidos Publications

Access to resources Recommend Favorite

The proteasome inhibitor Bortezomib (Velcade) as potential inhibitor of estrogen receptor‐positive breast cancer

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 137, Iss. 3, 2015-08 ,pp. : 686-697

John Wiley & Sons Inc

Access to resources Recommend Favorite

The 21-Gene Recurrence Score Assay (Oncotype DX™) in Estrogen Receptor-Positive Male Breast Cancer: Experience in an Israeli Cohort

By  

Oncology, Vol. 87, Iss. 1, 2014-06 ,pp. : 1-6

Karger

Access to resources Recommend Favorite